Suggestions
Christopher Rathermel
VP @ C2N | Healthcare IT, Security
Christopher Rathermel serves as the Vice President of Information Technology at C2N Diagnostics, a company focused on advancing the early diagnosis and treatment of Alzheimer's disease and related neurodegenerative conditions. With over two decades of experience in the field, Rathermel is responsible for driving technological innovation and ensuring operational excellence within the organization.12
C2N Diagnostics, co-founded by prominent scientists from Washington University School of Medicine, utilizes advanced mass spectrometry techniques to develop diagnostic tests aimed at detecting brain amyloid, a key indicator of Alzheimer's disease. The company operates a CLIA-certified laboratory in St. Louis, Missouri, and is actively pursuing FDA approval for its innovative blood-based diagnostic tests.1
